Fox Run Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,182
Closed -$72.9K 1290
2026
Q1
$72.9K Buy
+14,182
New +$79.6K 0.01% 852
2025
Q2
Sell
-15,388
Closed -$122K 1222
2025
Q1
$122K Buy
+15,388
New +$156K 0.02% 851
2024
Q2
Sell
-50,533
Closed -$763K 1072
2024
Q1
$763K Buy
+50,533
New +$917K 0.16% 229
2023
Q4
Sell
-50,636
Closed -$941K 1017
2023
Q3
$941K Buy
50,636
+11,583
+30% +$270K 0.28% 86
2023
Q2
$989K Buy
+39,053
New +$983K 0.28% 87

Other funds holding TDOC

Fox Run Management's TDOC Position: Q2 2026 in Review

Fox Run Management sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 14,182 shares — an estimated $72.9K sold.

Fox Run Management first reported a position in TDOC in Q2 2023 and held it in 5 quarters. The position peaked at $989K in Q2 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Fox Run Management reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 14,182 Teladoc Health shares in Q2 2026, an estimated $72.9K.
  • Fox Run Management first reported a position in Teladoc Health in Q2 2023 and held it in 5 quarters.
  • Fox Run Management's Teladoc Health position peaked at $989K in Q2 2023.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.